Eugene

[email protected]

LATEST

FDA Issues Form 483 to Sun Pharma for Mfg Violations
By

By
The US Food and Drug Administration (FDA) has issued a Form 483 with four observations to Sun Pharmaceutical Industries following a pre-approval inspection of the company’s facility in Halol, Gujarat,…

Valisure Submits Citizen Petition to FDA For DMF Impurity in Valsartan
By

By
New Haven, Connecticut-based Valisure, an online pharmacy, has submitted a citizen petition to the US Food and Drug Administration (FDA) to request that the FDA take certain actions following the…

Track-and-Trace Provider Kit Check Selected for FDA Pilot Program
By

By
Kit Check, a provider of automated medication management solutions for hospitals, has announced it has been accepted into a pilot program by the US Food and Drug Administration Act for…

Gilead, Nurix in $2.3-Bn Pact for Protein-Degradation Drugs for Cancer
By

By
Gilead and Nurix Therapeutics, a drug-discovery company specializing in the body’s natural process to control protein levels, have entered into a global collaboration to discover, develop and commercialize targeted protein…

BMS to Divest Celgene’s Blockbuster Drug Otezla in $74-Bn Pending Merger
By

By
Bristol-Myers Squibb (BMS) has provided an update on the approval process and timeline for its pending $74-billion acquisition of Celgene. To allow the transaction to close on a timely basis…

AbbVie To Acquire Allergan for $63 Billion
By

By
AbbVie and Allergan have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash-and-stock transaction for a transaction equity value of approximately $63 billion, based…

Lonza, Piramal, LSNE, Tergus Pharma Expand; Aptar Makes Two Acquisitions
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Lonza, Piramal Pharma Solutions, Tergus Pharma, LSNE, Aptar, and Rentschler Fill Solutions. Chemicals/Chemical API Manufacturing Lonza To Expand HPAPI…

Sanofi Teams Up With Google To Create New Virtual Innovation Lab
By

By
Sanofi has teamed up with Google to create a new virtual Innovation Lab, where the two companies will apply Google’s technology and analytics with Sanofi’s data to change how Sanofi…

Momenta, Sandoz Settle Generic Lovenox Suit with Amphastar
By

By
Momenta Pharmaceuticals, a biopharmaceutical company developing therapeutics for rare immune-mediated diseases and biosimilars, and Sandoz AG, the generics arm of Novartis, have settled litigation with Amphastar Pharmaceuticals, a specialty and…

Dr. Reddy’s Divests Rights to Two Neurology Products to Upsher-Smith
By

By
Dr. Reddy’s Laboratories, a Hyderabad, India-based pharmaceutical company, has entered into a definitive asset purchase agreement with Upsher-Smith Laboratories, a generics and brands pharmaceutical company, in which Dr. Reddy’s would…